November 2024
168 articles-
Nov 28 · 21:02Biotechnology Daily
Galapagos investor signals intent to influence company's control, argues the biotech is 'deeply undervalued'
-
Nov 28 · 21:00Biotechnology Daily
Dexcom's Stelo, its first over-the-counter glucose monitor, hits the market
-
Nov 28 · 20:56Biotechnology Daily
Procept BioRobotics stock jumps on FDA nod for prostate surgery system
-
Nov 28 · 20:51Bio Business News
Lykos' woes mount as FDA expands probe into its MDMA-based research: WSJ
-
Nov 28 · 20:48Bio Business News
After phase 2 fail, Actinogen reports new data in bid to salvage depression drug xanamem
-
Nov 28 · 20:47Bio Business News
MBX files for IPO, seeking cash to take challenger to Ascendis' Yorvipath into phase 3
-
Nov 28 · 20:44Bio Business News
Preclinical gene editor Tome is laying off 131 staffers, virtually its entire workforce
-
Nov 27 · 22:04Biotechnology Daily
Bicara and Zenas file for IPOs to push late-phase prospects toward finish line
-
Nov 27 · 22:01Biotechnology Daily
Tweaking one setting on mechanical ventilators may help protect patients from lung injury
-
Nov 27 · 21:59Biotechnology Daily
Eli Lilly seeks new angle on high-value target, tapping Oblique for antibody discovery push
-
Nov 27 · 21:56Biotechnology Daily
While FDA mulls Zevra's rare disease med, Rafael merges with Cyclo to push their rival candidate
-
Nov 27 · 21:54Bio Business News
Despite mixed market, a venture capital revival could be coming in Europe: PitchBook
-
Nov 27 · 21:52Bio Business News
After $213M round, gene editing biotech Tome shrinks operations as investor sentiment worsens
-
Nov 27 · 21:51Bio Business News
Biopharma VC hit highest quarterly level since 2022, but challenges in exit landscape remain
-
Nov 27 · 21:49Bio Business News
Ex-GSK CEO takes up board post at aging and obesity biotech BioAge
-
Nov 26 · 22:28Biotechnology Daily
Novartis, Versant hope to repeat Chinook’s success by arming kidney biotech Borealis with $150M
-
Nov 26 · 22:27Biotechnology Daily
Roche ramps up lab testing capacity for mpox worldwide following WHO declaration
-
Nov 26 · 22:06Biotechnology Daily
BioMarin creates new-look R&D and deal teams with Roche’s Sabry, Amgen’s Friberg
-
Nov 26 · 21:46Biotechnology Daily
FDA rejects Regeneron's blood cancer bispecific, delaying would-be challenger to J&J and Pfizer
-
Nov 26 · 21:44Bio Business News
Researchers receive $6.9M grant for tau-targeting drug with potential in Alzheimer's and beyond
-
Nov 26 · 21:43Bio Business News
BridgeBio launches another offshoot with $300M and early genetic disease programs
-
Nov 26 · 21:41Bio Business News
PreciseDx picks up $20.7M to advance AI-based breast cancer risk assessment
-
Nov 26 · 21:39Bio Business News
Medtech VC investment held steady in Q2 with $3.3B of deal value: PitchBook
-
Nov 25 · 22:48Biotechnology Daily
Despite cash infusion, Windtree still faces money running out within a year